Treatment of the positive surgical margin following radical prostatectomy

Chinese Medical Journal

Volumn 121, Issue 4, 2008, Pages 375-379

  Yang, Yong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Positive surgical margin; Prostate cancer; Radical prostatectomy

Indexed keywords

ANTIANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ERECTILE DYSFUNCTION; GLEASON SCORE; HUMAN; LYMPH NODE METASTASIS; MEDLINE; PELVIS LYMPH NODE; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; URINE INCONTINENCE; ARTICLE; MALE; PROSTATE TUMOR;

HUMANS; MALE; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 41649111312     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200802020-00017     Document Type: Review

References (30)

1. Xia YB. An analysis of data utilization of high risk area for cancer in China. Bull Chin Cancer (Chin) 2005; 14: 562-569.
2. Xu ZB, Wang GM, Sun LA, Zhang YK. The incidence of prostatic carcinoma in Shanghai. Chin J Clin Med (Chin) 2003; 10: 344-346.
3. Ian LH, Li H, Yang Y, Ho CF. Comparisons of the incidence and pathological characteristics of prostate cancer between Chinese and Portuguese in Macau. Chin Med J 2008; 121: 292-294.
4. Collette L, van Poppel H, Bolla M, van Cangh P, Vekemans K, Pozzo LD, et al. Patients at high risk of progression after radical prostatectomy: Do they all benefit from immediate post-operative irradiation? (EORTC trial 22911). Eur J Cancer 2005; 41: 2662-2672.
5. Touijer K, Kuroiwa K, Eastham JA, Vickers A, Reuter VE, Scardino PT, et al. Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy. Eur Urol 2007; 52: 1090-1096.
6. Tsuboi T, Ohori M, Kuroiwa K, Reuter VE, Kattan MW, Eastham JA, et al. Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins? Urology 2005; 66: 1287-1291.
7. Gaston SM, Soares M, Siddiqui MM, Dang V, Brice M, Shih J, et al. Tissue-print and print-phoresis as platform technologies for the molecular analysis of human surgical specimens: mapping tumor invasion of the prostate capsule. Nat Med 2005; 11: 95-101.
8. Karakiewicz PI, Eastham JA, Graefen M, Cagiannos I, Stricker PD, Klein E, et al. Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients. Urology 2005; 66: 1245-1250.
9. Swindle P, Eastham JA, Ohori M, Kattari MW, Wheeler T, Maru N, et al. Do margins matters? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 2005; 174: 903-907.
10. Secin FP, Serio A, Bianco FJ Jr, Karanikolas NT, Kuroiwa K, Vickers A, et al. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer. Eur Urol 2007; 51: 764-771.
11. Chun FK, Briganti A, Jeldres C, Gallina A, Erbersdobler A, Schlomm T, et al. Tumour volume and high grade tumour volume are the best predictors of pathologic stage and biochemical recurrence after radical prostatectomy. Eur J Cancer 2007; 43: 536-543.
12. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol 1994; 152 (5 Pt 2): 1850-1857.
13. Epstein JI. Incidence and significance of positive margins in radical prostatectomy specimens. Urol Clin North Am 1996; 23: 651-663.
14. Eastham JA, Kattan MW, Riedel E, Begg CB, Wheeler TM, Gerigk C, et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens. J Urol 2003; 170 (6 Pt 1): 2292-2295.
15. Grossfeld GD, Chang JJ, Broering JM, Miller DP, Yu J, Flanders SC, et al. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy? Urology 2000; 56: 430-435.
16. Ho SF, Lao HF, Li K, Tse MK. Clinical results of radical prostatectomy for patients with prostate cancer in Macau. Chin Med J 2008; 121: 295-298.
17. Guillonneau B, el-Fettouh H, Baumert H, Cathelineau X, Doublet JD, Fromont G, et al. Laparoscopic radical prostatectomy: oncological evaluation after 1,000 cases a Montsouris Institute. J Urol 2003; 169: 1261-1266.
18. Gufinther M, Hoggenmiller C, Alschibaja M, Hartung R, Paul R. Prognostic significance of location and extension of positive surgical margins after radical retropubic prostatectomy. Eur Urol 2004; (Suppl 3): 46.
19. Soulie M, Seguin P, Benoit J, Escourrou G, Tollon C, Vazzoler N, et al. Impact of a modified apical dissection during radical retropubic prostatectomy on the occurrence of positive surgical margins: a comparative study in 212 patients. Urology 2001; 58: 217-221.
20. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152 (5 Pt 2): 1831-1836.
21. Laven BA, Alsikafi NF, Yang XJ, Brendler CB. Minor modifications in apical dissection of radical retropubic prostatectomy in patients with clinical stage T2 prostate cancer reduce positive surgical margin incidence. Urology, 2004; 63: 95-98.
22. Palisaar RJ, Noldus J, Graefen M, Erbersdobler A, Haese A, Huland H. Influence of nerve-sparing (NS) procedure during radical prostatectomy (RP) on margin status and biochemical failure. Eur Urol 2005; 47: 176-184.
23. Ward JF, Zincke H, Bergstralh EJ, Slezak JM, Myers RP, Blute ML. The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy. J Urol 2004; 172 (4 Pt 1): 1328-1332.
24. Gaker DL, Steel BL. Radical prostatectomy with preservation of urinary continence: pathology and long-term results. J Urol 2004; 172 (6 Pt 2): 2549-2552.
25. Simon MA, Kim S, Soloway MS. Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins. J Urol 2006; 175: 140-144; discussion 144-145.
26. Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, et al. European Organization for Research and Treatment of Cancer. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet 2005; 366: 572-578.
27. Thompson IM Jr, Tingen CM, Paradelo J, Lucia MS, Miller G, Troyer D, et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial. JAMA 2006; 296: 2329-2335.
28. Stephenson AJ, Shariat SF, Zelefsky MJ, Kattan MW, Butler EB, Teh BS, et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004; 291: 1325-1332.
29. Moul JW, Wu H, Sun L, Mcleod DG, Amling C, Donahue T, et al. Early versus delayed hormonal therapy for prostate specific antigen only recurrence of prostate cancer after radical prostatectomy. J Urol 2004; 171: 1141-1147.
30. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prosate cancer (an EORTC study): a phase III randomised trial. Lancet 2002; 360: 103-106.